Tue.Jul 22, 2025

article thumbnail

Q&A: Supporting Ongoing Insulin Use Through Pharmacy Counseling

Drug Topics

Pharmacists play a key role in monitoring insulin use by addressing dosing, storage, and symptom management through regular, supportive patient check-ins.

article thumbnail

Sanofi $1.6 billion acquisition to advance respiratory vaccines

European Pharmaceutical Review

Sanofi has agreed to acquire the biotech Vicebio for an upfront payment of $1.15 billion, supporting the advancement of respiratory virus vaccines. In addition to the initial payment, Sanofi will pay up to $450 million, subject to achieved development and regulatory milestones. The deal intends to expand capabilities in vaccine design and development and will enable Sanofi to add a non-mRNA vaccine to its development pipeline.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Pharmacists Can Simplify the Vaccine Schedule

Pharmacy Times

News All News FDA Updates Press Releases Media All Videos Digital Detail Independent Corner Insights Interviews MEDcast Medical World News Microsites Peer Exchange Perfect Consult Podcasts Practice Pearls Sponsored Webcast Student Voices Webinars/Webcasts Conferences Conference Coverage Conference Listing Publications Pharmacy Times Pharmacy Practice in Focus: Oncology Pharmacy Practice in Focus: Health Systems Pharmacy Careers All Publications About the Publications Author Submission Submit to

article thumbnail

AstraZeneca Commits $50 Billion to US Manufacturing and R&D Efforts by 2030

Pharmaceutical Commerce

News News Pharma Pulse Academy Publications Partner Perspectives Webcasts Resources Conferences Conference Coverage Conference Listing Events Videos Videos Peer Exchange Podcasts Editorial Podcasts Sponsored Podcasts Subscribe Choose Specialty Brand & Product Security Brand & Product Security Brand & Product Security Brand & Product Security Business and Finance Cold Chain Cold Chain Cold Chain Cold Chain Commercial Channels Data & Technology Data & Technology Data &

article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

Shaping Pharmacy Research With Purpose and Public Impact

Pharmacy Times

News All News FDA Updates Press Releases Media All Videos Digital Detail Independent Corner Insights Interviews MEDcast Medical World News Microsites Peer Exchange Perfect Consult Podcasts Practice Pearls Sponsored Webcast Student Voices Webinars/Webcasts Conferences Conference Coverage Conference Listing Publications Pharmacy Times Pharmacy Practice in Focus: Oncology Pharmacy Practice in Focus: Health Systems Pharmacy Careers All Publications About the Publications Author Submission Submit to

article thumbnail

PhoreMost unveils platform to streamline molecular glue drug discovery

Pharma Times

Subscribe Advertise About us Follow Follow Follow Follow GO Magazine PharmaTimes Magazine Archive Web Exclusives News Competitions Appointments Business Insights Webinars Thought Leadership PhoreMost unveils platform to streamline molecular glue drug discovery by John Pinching | 22nd Jul 2025 | News GlueSEEKER enables rational design of targeted protein degraders PhoreMost has published new data validating its GlueSEEKER platform, a high-throughput technology designed to accelerate molecular glu

FDA

More Trending

article thumbnail

How Pharmacist Careers Are Shifting After COVID-19

Drug Topics

News FDA Updates Law and Advocacy Technology Trends Viewpoints All News Media In-Depth Insights Pharmacist View Script-Ed Expert Interviews Podcasts Conferences Conference Coverage Conference Listing Resources Disease Awareness White Board Video American Pharmacists Month Sponsored Resources CME/CE Partners Publications Drug Topics Journal Total Pharmacy Journal Submission of Articles Events Virtual Events Total Pharmacy Solutions Summit Business Business Strategies Patient Services Pharmacy Inv

article thumbnail

FDA Moving to Nonanimal Testing Methodologies in Preclinical Research

Pharmacy Times

News All News FDA Updates Press Releases Media All Videos Digital Detail Independent Corner Insights Interviews MEDcast Medical World News Microsites Peer Exchange Perfect Consult Podcasts Practice Pearls Sponsored Webcast Student Voices Webinars/Webcasts Conferences Conference Coverage Conference Listing Publications Pharmacy Times Pharmacy Practice in Focus: Oncology Pharmacy Practice in Focus: Health Systems Pharmacy Careers All Publications About the Publications Author Submission Submit to

FDA
article thumbnail

Flu Vaccine Benefits Both Vaccinated, Unvaccinated Patients

Drug Topics

Flu vaccination significantly reduces illness in both vaccinated and unvaccinated individuals, highlighting its importance in public health strategies.

article thumbnail

The Changing Landscape of Pharmacy Accessibility

Pharmacy Times

News All News FDA Updates Press Releases Media All Videos Digital Detail Independent Corner Insights Interviews MEDcast Medical World News Microsites Peer Exchange Perfect Consult Podcasts Practice Pearls Sponsored Webcast Student Voices Webinars/Webcasts Conferences Conference Coverage Conference Listing Publications Pharmacy Times Pharmacy Practice in Focus: Oncology Pharmacy Practice in Focus: Health Systems Pharmacy Careers All Publications About the Publications Author Submission Submit to

article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

Financial Strains in Pharmacy Leading to New Clinical Service Models

Drug Topics

In part 4 of our interview with Michael Kleinrock, lead director of research at IQVIA, he discussed how trends in medication use are currently impacting pharmacy businesses.

article thumbnail

Once-Daily Alixorexton Improves Wakefulness at All Doses in Patients With Narcolepsy Type 1

Pharmacy Times

News All News FDA Updates Press Releases Media All Videos Digital Detail Independent Corner Insights Interviews MEDcast Medical World News Microsites Peer Exchange Perfect Consult Podcasts Practice Pearls Sponsored Webcast Student Voices Webinars/Webcasts Conferences Conference Coverage Conference Listing Publications Pharmacy Times Pharmacy Practice in Focus: Oncology Pharmacy Practice in Focus: Health Systems Pharmacy Careers All Publications About the Publications Author Submission Submit to

article thumbnail

EMA Marketing Authorization of New Drugs in June 2025  

PharmaShots

Shots: The EMA’s CHMP has granted positive opinions and approvals to 2 Biologics and 6 new chemical entities in June 2025, leading to treatments for patients and advances in the healthcare industry The major highlighted drug was SpringWorks Therapeutics’ Ogsiveo to Treat Desmoid Tumours PharmaShots has compiled a list of 8 drugs that have been granted positive opinions and approvals by the EC, respectively Italfarmaco Obtains the EC’s Conditional Approval for Duvyzat to Treat Duchenne Muscul

article thumbnail

How AI Brings Pharmacogenetics to the Frontline of Precision Medicine

Pharmacy Times

News All News FDA Updates Press Releases Media All Videos Digital Detail Independent Corner Insights Interviews MEDcast Medical World News Microsites Peer Exchange Perfect Consult Podcasts Practice Pearls Sponsored Webcast Student Voices Webinars/Webcasts Conferences Conference Coverage Conference Listing Publications Pharmacy Times Pharmacy Practice in Focus: Oncology Pharmacy Practice in Focus: Health Systems Pharmacy Careers All Publications About the Publications Author Submission Submit to

article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

article thumbnail

Is Pharma Marketing Email Dead or Just Getting Started with AI?

Pharma Marketing Network

In the fast-paced world of healthcare communications, email remains both a relic and a revelation. Some say Pharma Marketing Email is losing relevance amid data privacy constraints and rising digital noise. Yet others argue it’s just beginning to show its full potential—especially with the rise of artificial intelligence. So, is pharma email marketing truly a dying breed or a channel reborn?

article thumbnail

PillPack From Amazon Pharmacy Expands Into Medicare Part D Services: Inside Its PillPack, Caregiver Tools, and AI-Powered Pharmacy Vision

Pharmacy Times

From AI-powered prescription fulfillment to the expansion of PillPack for Medicare patients, Carey outlines how Amazon Pharmacy is streamlining access, improving affordability, and setting the stage for a more patient-centered health care future.

article thumbnail

The Ripple Effect of 200% Tariffs on US Drug Supply and Pricing

Pharmaceutical Commerce

In the first part of his video interview with Pharma Commerce Editor Nicholas Saraceno, Brad Stewart, BDO’s national life sciences co-leader, describes the immediate and long-term impacts of this potential levy on pharma imports.

article thumbnail

MetP Pharma releases positive data on intranasal semaglutide administration

Pharmafile

MetP Pharma has released new data highlighting the advantages of its MetP technology in delivering neuroactive peptides, particularly semaglutide, directly to the brain though the intranasal route. This opens up the possibility of the platform being used for a wide range of neuroactive therapeutics, from metabolic to neurodegenerative diseases. The data demonstrates that the MetP […] The post MetP Pharma releases positive data on intranasal semaglutide administration appeared first on Phar

article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

Extremely Severe Pediatric Obesity Prevalence Increased Over Last 15 Years

Drug Topics

News FDA Updates Law and Advocacy Technology Trends Viewpoints All News Media In-Depth Insights Pharmacist View Script-Ed Expert Interviews Podcasts Conferences Conference Coverage Conference Listing Resources Disease Awareness White Board Video American Pharmacists Month Sponsored Resources CME/CE Partners Publications Drug Topics Journal Total Pharmacy Journal Submission of Articles Events Virtual Events Total Pharmacy Solutions Summit Business Business Strategies Patient Services Pharmacy Inv

article thumbnail

Optimizing COPD Management Through Team-Based and Remote Care at UPMC

Pharmacy Times

UPMC Health Plan enhances COPD care through a multidisciplinary approach, leveraging telehealth, education, and pharmacist-led programs to optimize patient outcomes.

article thumbnail

J&J seeks FDA approval for icotrokinra to treat psoriasis

Pharmaceutical Technology

Skip to site menu Skip to page content Switch language: translate --> PT Menu Search Sections Home News Analysis Features Comment & Opinion Projects Data Insights Sectors Clinical Trials Drug Manufacturers Therapy Area Cardiovascular Central Nervous System Immunology Infectious Disease Oncology Respiratory Pricing and Market Access Themes Artificial Intelligence Corporate Governance Cloud Cybersecurity Environmental Sustainability Internet of Things Robotics Social Responsibility Covid-19 Insigh

FDA
article thumbnail

FDA Grants Priority Review to Update Label for Sotatercept-Csrk

Pharmacy Times

Results from the ZENITH trial show sotatercept's promise for pulmonary arterial hypertension treatment.

article thumbnail

Roche’s Itovebi Regimen Secures the EC’s Approval for PIK3CA-mutated Breast Cancer

PharmaShots

Shots: The EC has approved Itovebi + Ibrance & fulvestrant as a 1L therapy for adults with PIK3CA-mutated, ER+/HER2- locally advanced or metastatic breast cancer recurring on or within 12mos. of adj. endocrine therapy, based on the P-III ( INAVO120 ) trial Trial (n=325) assessed the regimen vs PBO + Ibrance & fulvestrant, which showed improved PFS (1EP) by 57% (mPFS: 15 vs 7.3mos.) & a 33% reduction in death risk, with consistent PFS benefit across subgroups; regimen delayed also CT

article thumbnail

Why Pharmacy Students Choose Patient-Facing, Non-Patient-Facing Roles

Drug Topics

With an emphasis on the factors that differentiate the future roles of pharmacists, researchers sought to better understand the career intentions of pharmacy students.

article thumbnail

Medicare patients face higher drug costs, despite IRA promises

PhRMA

Lawmakers promised that the Inflation Reduction Act (IRA) would make prescription drugs more affordable. But a new analysis from the USC Schaeffer Center shows that most Medicare beneficiaries could see higher out-of-pocket costs under the law.

article thumbnail

Inside AstraZeneca’s $50 Billion U.S. Plan

Pharma Marketing Network

AstraZeneca is making headlines again, this time with an ambitious $50 billion investment plan targeting the U.S. market. But what does this move signify for the pharmaceutical landscape, and more importantly, for American patients and healthcare providers? Think of it as a high-stakes chess match where AstraZeneca is positioning its knights, rooks, and queens with strategic intent, aiming to dominate key therapeutic areas and reshape the U.S. pharma market.

article thumbnail

Can dogs take buprenorphine?

The Checkup by Singlecare

Buprenorphine is a partial opioid agonist and is used to treat pain. Brand names for buprenorphine include Buprenex, Simbadol, and Belbuca. Buprenorphine is FDA approved for use in humans and cats , but not dogs. However, veterinarians often prescribe it off-label for dogs. Buprenorphine for dogs is used primarily to treat pain after surgeries or to treat certain chronic conditions that cause pain.

article thumbnail

Sarepta halts Elevidys shipments following FDA pressure

Pharmaceutical Technology

Skip to site menu Skip to page content Switch language: translate --> PT Menu Search Sections Home News Analysis Features Comment & Opinion Projects Data Insights Sectors Clinical Trials Drug Manufacturers Therapy Area Cardiovascular Central Nervous System Immunology Infectious Disease Oncology Respiratory Pricing and Market Access Themes Artificial Intelligence Corporate Governance Cloud Cybersecurity Environmental Sustainability Internet of Things Robotics Social Responsibility Covid-19 Insigh

FDA
article thumbnail

Novartis’ Zolgensma sales fall again as gene therapy market woes persist

PharmaVoice

Skip to main content CONTINUE TO SITE âžž Dont miss the most important voices in pharma Let PharmaVoices free newsletter keep you informed on what industry leaders are saying, straight from your inbox. By signing up to receive our newsletter, you agree to our Terms of Use and Privacy Policy. You can unsubscribe at anytime. Voices Q&A Profiles Biotech Spotlight First 90 Days Opinions Topics Biotech Commercialization Leadership Manufacturing Patient Pharma Policy & Regulation Research & Deve

FDA
article thumbnail

Bristol Myers Squibb Application for Psoriatic Arthritis Drug Accepted for Review in Four Regions

PharmTech

News All News Bio/Pharma News Publications All Publications PharmTech PharmTech Europe Resources Marketplace ICH Q9 Revision: A Comprehensive Resource on Quality Risk Management Peer-Reviewed Research PharmTech Products Pharma Insights Sponsored Podcasts Sponsored Videos Sponsored eBooks Whitepapers Webcasts Multimedia All Videos Ask the Expert Behind The Headlines Buy, Sell, Hold Drug Digest Videos Drug Solutions Podcast Peer Exchange Sexy Science Tech Talk Conference Conference Coverage Confer

article thumbnail

Bringing to life the full story of biopharmaceutical innovation and investments

PhRMA

This week, PhRMA re-launched Innovation.org – a platform that tells the story of the biopharmaceutical industry’s progress, transformative innovation and commitment to America’s patients, workers and communities.

article thumbnail

Coverage Gaps and Challenges Ahead for Obesity Drugs

Pharmaceutical Commerce

In the first part of his Pharma Commerce video interview, Hyung Heon Kim, CEO of MetaVia, describes the US payer ecosystem’s level of preparedness to support broader access and long-term affordability for these therapies.

article thumbnail

FDA Issues CRL to Replimune for Vusolimogene Oderparepvec With Nivolumab for Advanced Melanoma

Pharmacy Times

The complete response letter (CRL) did not raise safety concerns, but stated the IGNYTE trial was inadequate and did not provide substantial evidence of effectiveness.

FDA